$2.96 Billion in Sales Expected for Keurig Dr Pepper Inc (NYSE:KDP) This Quarter

Equities research analysts forecast that Keurig Dr Pepper Inc (NYSE:KDP) will report sales of $2.96 billion for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Keurig Dr Pepper’s earnings, with the highest sales estimate coming in at $2.99 billion and the lowest estimate coming in at $2.95 billion. Keurig Dr Pepper reported sales of $2.81 billion during the same quarter last year, which would suggest a positive year over year growth rate of 5.3%. The business is scheduled to report its next quarterly earnings results on Thursday, February 27th.

According to Zacks, analysts expect that Keurig Dr Pepper will report full year sales of $11.18 billion for the current financial year, with estimates ranging from $11.13 billion to $11.33 billion. For the next year, analysts forecast that the firm will report sales of $11.49 billion, with estimates ranging from $11.42 billion to $11.61 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover Keurig Dr Pepper.

Keurig Dr Pepper (NYSE:KDP) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.32 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.01. The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.86 billion. Keurig Dr Pepper had a net margin of 10.13% and a return on equity of 7.27%. The firm’s revenue was up 5.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.30 EPS.

Several research analysts have commented on KDP shares. Bank of America raised their price objective on Keurig Dr Pepper from $30.00 to $33.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Guggenheim restated a “hold” rating on shares of Keurig Dr Pepper in a report on Friday, September 27th. SunTrust Banks set a $35.00 price objective on shares of Keurig Dr Pepper and gave the stock a “buy” rating in a research note on Friday, September 27th. Morgan Stanley set a $24.00 target price on shares of Keurig Dr Pepper and gave the stock a “sell” rating in a report on Friday, August 9th. Finally, ValuEngine downgraded shares of Keurig Dr Pepper from a “hold” rating to a “sell” rating in a research report on Tuesday. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $30.49.

Shares of NYSE KDP traded up $0.13 during trading hours on Friday, reaching $30.13. The stock had a trading volume of 83,766 shares, compared to its average volume of 1,990,376. Keurig Dr Pepper has a 52-week low of $24.52 and a 52-week high of $32.00. The firm has a market cap of $43.53 billion, a price-to-earnings ratio of 28.97, a P/E/G ratio of 1.66 and a beta of 0.46. The business’s fifty day moving average price is $29.03 and its two-hundred day moving average price is $28.42. The company has a current ratio of 0.35, a quick ratio of 0.23 and a debt-to-equity ratio of 0.57.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Investors of record on Friday, January 3rd will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date of this dividend is Thursday, January 2nd. Keurig Dr Pepper’s payout ratio is currently 57.69%.

In other Keurig Dr Pepper news, insider Mary Beth Denooyer acquired 6,000 shares of the firm’s stock in a transaction dated Tuesday, September 17th. The stock was purchased at an average price of $27.69 per share, for a total transaction of $166,140.00. Also, Director Robert S. Singer acquired 1,500 shares of the stock in a transaction dated Monday, November 11th. The stock was acquired at an average cost of $29.02 per share, with a total value of $43,530.00. Following the transaction, the director now directly owns 53,001 shares in the company, valued at $1,538,089.02. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 82,500 shares of company stock worth $2,313,255. 0.44% of the stock is owned by corporate insiders.

A number of hedge funds have recently made changes to their positions in KDP. Strs Ohio raised its holdings in shares of Keurig Dr Pepper by 0.4% in the third quarter. Strs Ohio now owns 105,055 shares of the company’s stock worth $2,870,000 after buying an additional 405 shares during the last quarter. Great West Life Assurance Co. Can raised its stake in Keurig Dr Pepper by 1.2% in the 3rd quarter. Great West Life Assurance Co. Can now owns 42,528 shares of the company’s stock worth $1,163,000 after acquiring an additional 510 shares during the last quarter. Rational Advisors LLC raised its stake in Keurig Dr Pepper by 45.2% in the 3rd quarter. Rational Advisors LLC now owns 1,802 shares of the company’s stock worth $49,000 after acquiring an additional 561 shares during the last quarter. Raymond James Trust N.A. lifted its position in Keurig Dr Pepper by 7.3% during the 3rd quarter. Raymond James Trust N.A. now owns 8,349 shares of the company’s stock worth $228,000 after acquiring an additional 570 shares during the period. Finally, Catalyst Capital Advisors LLC lifted its position in Keurig Dr Pepper by 29.2% during the 3rd quarter. Catalyst Capital Advisors LLC now owns 2,520 shares of the company’s stock worth $69,000 after acquiring an additional 570 shares during the period. Hedge funds and other institutional investors own 20.53% of the company’s stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.

Recommended Story: How to Invest in Stocks with Increasing Dividends

Get a free copy of the Zacks research report on Keurig Dr Pepper (KDP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Keurig Dr Pepper (NYSE:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit